Citation 139010
YESILADA,E: USTUN,O: SEZIK,E: TAKAISHI,Y: ONO,Y: HONDA,G:. (1997). INHIBITORY EFFECTS OF TURKISH FOLK REMEDIES ON INFLAMMATORY CYTOKINES: INTERLEUKIN-1 ALPHA, INTERLEUKIN-1 BETA AND TUMOR NECROSIS FACTOR ALPHA.. 58(1)
Citation Details
| Title | INHIBITORY EFFECTS OF TURKISH FOLK REMEDIES ON INFLAMMATORY CYTOKINES: INTERLEUKIN-1 ALPHA, INTERLEUKIN-1 BETA AND TUMOR NECROSIS FACTOR ALPHA. |
|---|---|
| Authors | YESILADA,E: USTUN,O: SEZIK,E: TAKAISHI,Y: ONO,Y: HONDA,G: |
| Year | 1997 |
| Volume | 58 |
| Issue | 1 |
Summary
Year: 1997
Journal: Unknown
Organisms and Their Experiments (14)
Cistus laurifolius (CISTACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ANALGESIC ACTIVITY
| None | None | |
| 3 |
ANTIPYRETIC ACTIVITY
| None | None | |
| 4 |
ANTIINFLAMMATORY ACTIVITY
| None | None | |
| 5 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 6 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 7 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
|
| 8 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 9 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 10 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
|
| 11 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 12 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 13 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
|
| 14 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 15 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 16 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
|
| 17 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 18 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 19 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
Cistus laurifolius (CISTACEAE)
Clematis flammula (RANUNCULACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
DIURETIC ACTIVITY
| None | None | |
| 3 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 4 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 5 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 6 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 7 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 8 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 9 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 10 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 11 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 12 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 13 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 14 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
Crataegus tanacetifolia (ROSACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ANALGESIC ACTIVITY
| None | None | |
| 3 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 4 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 5 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 6 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 7 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 8 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 9 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 10 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 11 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 12 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 13 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 14 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 15 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 16 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 17 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
Crataegus orientalis (ROSACEAE)
Daphne oleoides (THYMELAEACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
| None | None | |
| 3 |
ANTICONVULSANT ACTIVITY
| None | None | |
| 4 |
ANTIPYRETIC ACTIVITY
| None | None | |
| 5 |
ANTIINFLAMMATORY ACTIVITY
| None | None | |
| 6 |
ANTIINFLAMMATORY ACTIVITY
| None | None | |
| 7 |
ANTIEDEMA ACTIVITY
| None | None | |
| 8 |
ANTIMALARIAL ACTIVITY
| None | None | |
| 9 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 10 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 11 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
|
| 12 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 13 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 14 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
|
| 15 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 16 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 17 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
|
| 18 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 19 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 20 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
|
| 21 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 22 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 23 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
Ecballium elaterium (CUCURBITACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ANTIINFLAMMATORY ACTIVITY
| None | None | |
| 3 |
ANTIJAUNDICE EFFECT
| None | None | |
| 4 |
ANTIINFLAMMATORY ACTIVITY
| None | None | |
| 5 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 6 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 7 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 8 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 9 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 10 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 11 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 12 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 13 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
|
| 14 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 15 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 16 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 17 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 18 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 19 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
Rosa canina (ROSACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ANTIBURN EFFECT
| None | None | |
| 3 |
ANTIDIARRHEAL ACTIVITY
| None | None | |
| 4 |
CARDIOTONIC ACTIVITY
| None | None | |
| 5 |
ANTIINFLAMMATORY ACTIVITY
| None | None | |
| 6 |
ANTITUSSIVE ACTIVITY
| None | None | |
| 7 |
BRONCHODILATOR ACTIVITY
| None | None | |
| 8 |
ANTIHEMORRHOIDAL ACTIVITY
| None | None | |
| 9 |
MISCELLANEOUS EFFECTS
| None | None | |
| 10 |
ANTITUSSIVE ACTIVITY
| None | None | |
| 11 |
HYPERGLYCEMIC ACTIVITY
| None | None | |
| 12 |
ANTIBACTERIAL ACTIVITY
| None | None | |
| 13 |
KIDNEY STONE DISSOLUTION EFFECT
| None | None | |
| 14 |
ANTIECZEMA EFFECT
| None | None | |
| 15 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 16 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 17 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 18 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 19 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 20 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 21 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 22 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 23 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 24 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 25 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 26 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
Rubus discolor (ROSACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 3 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 4 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
|
| 5 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 6 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 7 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 8 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 9 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 10 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 11 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 12 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 13 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
Rubus hirtus (ROSACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ANTIBACTERIAL ACTIVITY
| None | None | |
| 3 |
HEMOSTATIC ACTIVITY
| None | None | |
| 4 |
ANTIDIARRHEAL ACTIVITY
| None | None | |
| 5 |
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
| None | None | |
| 6 |
MISCELLANEOUS EFFECTS
| None | None | |
| 7 |
KIDNEY STONE DISSOLUTION EFFECT
| None | None | |
| 8 |
PSORIASIS TREATMENT
| None | None | |
| 9 |
ANTIINFLAMMATORY ACTIVITY
| None | None | |
| 10 |
CNS EFFECTS(GENERAL)
| None | None | |
| 11 |
ANTIHEMORRHOIDAL ACTIVITY
| None | None | |
| 12 |
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
| None | None | |
| 13 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 14 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 15 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
|
| 16 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 17 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 18 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 19 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 20 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 21 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 22 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 23 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 24 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
Sambucus ebulus (CAPRIFOLIACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ANTIECZEMA EFFECT
| None | None | |
| 3 |
ANTIINFLAMMATORY ACTIVITY
| None | None | |
| 4 |
ANTIINFLAMMATORY ACTIVITY
| None | None | |
| 5 |
ANALGESIC ACTIVITY
| None | None | |
| 6 |
ANALGESIC ACTIVITY
| None | None | |
| 7 |
ANTIBACTERIAL ACTIVITY
| None | None | |
| 8 |
ANTIVENIN EFFECT
| None | None | |
| 9 |
ANTIHEMORRHOIDAL ACTIVITY
| None | None | |
| 10 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 11 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 12 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
|
| 13 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 14 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 15 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
|
| 16 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 17 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 18 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
|
| 19 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 20 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 21 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 22 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 23 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 24 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
Sambucus ebulus (CAPRIFOLIACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 3 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 4 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 5 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 6 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 7 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
|
| 8 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 9 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 10 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
|
| 11 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 12 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 13 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 14 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 15 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 16 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|
Sambucus nigra (CAPRIFOLIACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 3 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 4 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
|
| 5 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 6 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 7 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
|
| 8 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 9 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 10 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 11 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 12 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 13 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
|
| 14 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 15 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 16 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
Sambucus nigra (CAPRIFOLIACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ANTIINFLAMMATORY ACTIVITY
| None | None | |
| 3 |
ANTIBACTERIAL ACTIVITY
| None | None | |
| 4 |
BENIGN PROSTATIC HYPERPLASIA IMPROVEMENT
| None | None | |
| 5 |
ANTIHEMORRHOIDAL ACTIVITY
| None | None | |
| 6 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 7 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 8 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
|
| 9 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 10 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 11 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 12 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 13 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 14 |
TUMOR NECROSING FACTOR INHIBITION
| None |
WEAK ACTIVITY
|
|
| 15 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 16 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
ACTIVE
|
|
| 17 |
TUMOR NECROSING FACTOR INHIBITION
| None |
ACTIVE
|
|
| 18 |
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
| None |
WEAK ACTIVITY
|
|
| 19 |
INTERLEUKIN-1-BETA RELEASE INHIBITION
| None |
INACTIVE
|
|
| 20 |
TUMOR NECROSING FACTOR INHIBITION
| None |
INACTIVE
|